Filtros : "Medicinal Chemistry" "Brasil" Limpar

Filtros



Limitar por data


  • Fonte: Medicinal Chemistry. Unidades: EACH, IQSC

    Assuntos: PÂNCREAS, ENZIMAS, QUÍMICA MÉDICA

    PrivadoAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MARTINS, Michelle C.M.R. et al. In silico studies on the interaction between bioactive ligands and DPP-IV: insights on potential candidates for the treatment of type 2 diabetes mellitus. Medicinal Chemistry, v. 17, n. 3, p. 247-263, 2021Tradução . . Disponível em: https://doi.org/10.2174/1573406416666200129151256. Acesso em: 18 nov. 2024.
    • APA

      Martins, M. C. M. R., Pantaleão, S. Q., Almeida, M. de O., Weber, K. C., & Honório, K. M. (2021). In silico studies on the interaction between bioactive ligands and DPP-IV: insights on potential candidates for the treatment of type 2 diabetes mellitus. Medicinal Chemistry, 17( 3), 247-263. doi:10.2174/1573406416666200129151256
    • NLM

      Martins MCMR, Pantaleão SQ, Almeida M de O, Weber KC, Honório KM. In silico studies on the interaction between bioactive ligands and DPP-IV: insights on potential candidates for the treatment of type 2 diabetes mellitus [Internet]. Medicinal Chemistry. 2021 ; 17( 3): 247-263.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2174/1573406416666200129151256
    • Vancouver

      Martins MCMR, Pantaleão SQ, Almeida M de O, Weber KC, Honório KM. In silico studies on the interaction between bioactive ligands and DPP-IV: insights on potential candidates for the treatment of type 2 diabetes mellitus [Internet]. Medicinal Chemistry. 2021 ; 17( 3): 247-263.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2174/1573406416666200129151256
  • Fonte: Medicinal Chemistry. Unidade: FCF

    Assuntos: AGENTES ANTIMICROBIANOS, ANTIOXIDANTES, RESISTÊNCIA MICROBIANA ÀS DROGAS

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FERNANDES, Thais Batista et al. Design of arylsulfonylhydrazones as potential FabH inhibitors: synthesis, antimicrobial evaluation and molecular docking. Medicinal Chemistry, v. 17, p. 474-484, 2021Tradução . . Disponível em: https://doi.org/10.2174/1573406415666191122111228. Acesso em: 18 nov. 2024.
    • APA

      Fernandes, T. B., Segretti, N. D., Lourenço, F. R., Cândido, T. M., Baby, A. R., Barbosa, E. G., & Parise Filho, R. (2021). Design of arylsulfonylhydrazones as potential FabH inhibitors: synthesis, antimicrobial evaluation and molecular docking. Medicinal Chemistry, 17, 474-484. doi:10.2174/1573406415666191122111228
    • NLM

      Fernandes TB, Segretti ND, Lourenço FR, Cândido TM, Baby AR, Barbosa EG, Parise Filho R. Design of arylsulfonylhydrazones as potential FabH inhibitors: synthesis, antimicrobial evaluation and molecular docking [Internet]. Medicinal Chemistry. 2021 ; 17 474-484.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2174/1573406415666191122111228
    • Vancouver

      Fernandes TB, Segretti ND, Lourenço FR, Cândido TM, Baby AR, Barbosa EG, Parise Filho R. Design of arylsulfonylhydrazones as potential FabH inhibitors: synthesis, antimicrobial evaluation and molecular docking [Internet]. Medicinal Chemistry. 2021 ; 17 474-484.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2174/1573406415666191122111228
  • Fonte: Medicinal Chemistry. Unidade: EACH

    Assuntos: LEISHMANIA MEXICANA, ENZIMAS, QUÍMICA MÉDICA

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ALVES, Krisnna M.A. et al. Design of Inhibitors for Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Enzyme of Leishmania mexicana. Medicinal Chemistry, v. 16, n. 6, p. 784-795, 2020Tradução . . Disponível em: https://doi.org/10.2174/1573406415666190712111139. Acesso em: 18 nov. 2024.
    • APA

      Alves, K. M. A., Cardoso, F. J. B., Honório, K. M., & Molfetta, F. A. de. (2020). Design of Inhibitors for Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Enzyme of Leishmania mexicana. Medicinal Chemistry, 16( 6), 784-795. doi:10.2174/1573406415666190712111139
    • NLM

      Alves KMA, Cardoso FJB, Honório KM, Molfetta FA de. Design of Inhibitors for Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Enzyme of Leishmania mexicana [Internet]. Medicinal Chemistry. 2020 ; 16( 6): 784-795.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2174/1573406415666190712111139
    • Vancouver

      Alves KMA, Cardoso FJB, Honório KM, Molfetta FA de. Design of Inhibitors for Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Enzyme of Leishmania mexicana [Internet]. Medicinal Chemistry. 2020 ; 16( 6): 784-795.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2174/1573406415666190712111139
  • Fonte: Medicinal Chemistry. Unidade: FCF

    Assuntos: MOLÉCULA, ANTINEOPLÁSICOS

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      VASCONCELOS, Stanley Nunes Siqueira et al. Synthesis of a Tyr-Tyr dipeptide library and evaluation against tumor cells. Medicinal Chemistry, v. 14, n. 7, p. 709-714, 2018Tradução . . Disponível em: https://doi.org/10.2174/1573406414666180309153142. Acesso em: 18 nov. 2024.
    • APA

      Vasconcelos, S. N. S., Sciani, J. M., Lisboa, N. M., & Stefani, H. A. (2018). Synthesis of a Tyr-Tyr dipeptide library and evaluation against tumor cells. Medicinal Chemistry, 14( 7), 709-714. doi:10.2174/1573406414666180309153142
    • NLM

      Vasconcelos SNS, Sciani JM, Lisboa NM, Stefani HA. Synthesis of a Tyr-Tyr dipeptide library and evaluation against tumor cells [Internet]. Medicinal Chemistry. 2018 ; 14( 7): 709-714.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2174/1573406414666180309153142
    • Vancouver

      Vasconcelos SNS, Sciani JM, Lisboa NM, Stefani HA. Synthesis of a Tyr-Tyr dipeptide library and evaluation against tumor cells [Internet]. Medicinal Chemistry. 2018 ; 14( 7): 709-714.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2174/1573406414666180309153142
  • Fonte: Medicinal Chemistry. Unidades: FCF, EACH

    Assuntos: FÁRMACOS, RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PANTALEÃO, Simone Queiroz et al. The role of QSAR and virtual screening studies in type 2 diabetes drug discovery. Medicinal Chemistry, v. 13, p. 706-720, 2017Tradução . . Disponível em: https://doi.org/10.2174/1573406413666170522152102. Acesso em: 18 nov. 2024.
    • APA

      Pantaleão, S. Q., Fujii, D. G. V., Maltarollo, V. G., Silva, D. da C., Trossini, G. H. G., Weber, K. C., & Honório, K. M. (2017). The role of QSAR and virtual screening studies in type 2 diabetes drug discovery. Medicinal Chemistry, 13, 706-720. doi:10.2174/1573406413666170522152102
    • NLM

      Pantaleão SQ, Fujii DGV, Maltarollo VG, Silva D da C, Trossini GHG, Weber KC, Honório KM. The role of QSAR and virtual screening studies in type 2 diabetes drug discovery [Internet]. Medicinal Chemistry. 2017 ; 13 706-720.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2174/1573406413666170522152102
    • Vancouver

      Pantaleão SQ, Fujii DGV, Maltarollo VG, Silva D da C, Trossini GHG, Weber KC, Honório KM. The role of QSAR and virtual screening studies in type 2 diabetes drug discovery [Internet]. Medicinal Chemistry. 2017 ; 13 706-720.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2174/1573406413666170522152102
  • Fonte: Medicinal Chemistry. Unidade: IFSC

    Assuntos: PROTEÍNAS, FÍSICA DA MATÉRIA CONDENSADA

    PrivadoAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      OLIVEIRA, Guilherme A. L. et al. Bergenin from peltophorum dubium: isolation, characterization, and antioxidant activities in non-biological systems and erythrocytes. Medicinal Chemistry, v. 13, n. 6, p. 592-603, 2017Tradução . . Disponível em: https://doi.org/10.2174/1573406413666170306120152. Acesso em: 18 nov. 2024.
    • APA

      Oliveira, G. A. L., Oliveira, G. L. da S., Nicolau, L. A. D., Mafud, A. C., Batista, L. F., Mascarenhas, Y. P., et al. (2017). Bergenin from peltophorum dubium: isolation, characterization, and antioxidant activities in non-biological systems and erythrocytes. Medicinal Chemistry, 13( 6), 592-603. doi:10.2174/1573406413666170306120152
    • NLM

      Oliveira GAL, Oliveira GL da S, Nicolau LAD, Mafud AC, Batista LF, Mascarenhas YP, Souza LKM, David JM, Pinto LS, Alves CQ, Medeiros JVR. Bergenin from peltophorum dubium: isolation, characterization, and antioxidant activities in non-biological systems and erythrocytes [Internet]. Medicinal Chemistry. 2017 ; 13( 6): 592-603.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2174/1573406413666170306120152
    • Vancouver

      Oliveira GAL, Oliveira GL da S, Nicolau LAD, Mafud AC, Batista LF, Mascarenhas YP, Souza LKM, David JM, Pinto LS, Alves CQ, Medeiros JVR. Bergenin from peltophorum dubium: isolation, characterization, and antioxidant activities in non-biological systems and erythrocytes [Internet]. Medicinal Chemistry. 2017 ; 13( 6): 592-603.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2174/1573406413666170306120152
  • Fonte: Medicinal Chemistry. Unidade: IQSC

    Assuntos: QUÍMICA MÉDICA, ESTRÓGENOS

    PrivadoAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SANGI, Diego P. et al. Molecular design, synthesis and evaluation of 2,3-diarylquinoxalines as estrogen receptor ligands. Medicinal Chemistry, v. 11, n. 8, p. 736-746, 2015Tradução . . Disponível em: https://doi.org/10.2174/1573406411666150513093039. Acesso em: 18 nov. 2024.
    • APA

      Sangi, D. P., Cominetti, M. R., Becceneri, A. B., Resende, F. A., Varanda, E. A., Montanari, C. A., et al. (2015). Molecular design, synthesis and evaluation of 2,3-diarylquinoxalines as estrogen receptor ligands. Medicinal Chemistry, 11( 8), 736-746. doi:10.2174/1573406411666150513093039
    • NLM

      Sangi DP, Cominetti MR, Becceneri AB, Resende FA, Varanda EA, Montanari CA, Paixão MW, Corrêa AG. Molecular design, synthesis and evaluation of 2,3-diarylquinoxalines as estrogen receptor ligands [Internet]. Medicinal Chemistry. 2015 ; 11( 8): 736-746.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2174/1573406411666150513093039
    • Vancouver

      Sangi DP, Cominetti MR, Becceneri AB, Resende FA, Varanda EA, Montanari CA, Paixão MW, Corrêa AG. Molecular design, synthesis and evaluation of 2,3-diarylquinoxalines as estrogen receptor ligands [Internet]. Medicinal Chemistry. 2015 ; 11( 8): 736-746.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2174/1573406411666150513093039

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2024